Probiotics in acne and rosacea

Cutis

Volumn 92, Issue 1, 2013, Pages 6-7

  Bowe, Whitney P ^a  

^a Downstate Health Sciences University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ACNE VULGARIS; EDITORIAL; HUMAN; INTRADERMAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; ROSACEA;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; HUMANS; PROBIOTICS; ROSACEA;

EID: 84883797791     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Prince T, McBain AJ, O'Neill CA. Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion [published online ahead of print May 11, 2012]. Appl Environ Microbiol. 2012;78:5119-5126.
2. Bowe WP, Filip JC, DiRienzo JM, et al. Inhibition of Propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J Drugs Dermatol. 2006;5:868-870.
3. Gueniche A, Benyacoub J, Philippe D, et al. Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro [published online ahead of print October 22, 2010]. Eur J Dermatol. 2010;20:731-737.
4. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis-back to the future? Gut Pathog. 2011;3:1.
5. Hacini-Rachinel F, Gheit H, Le Luduec JB, et al. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells [published online ahead of print March 20, 2009]. PLoS One. 2009;4:e4903.
6. Hsieh FC, Lee CL, Chai CY, et al. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab (Lond). 2013;10:35.
7. Veith WB, Silverberg NB. The association of acne vulgaris with diet. Cutis. 2011;88:84-91.
8. Zhang H, Liao W, Chao W, et al. Risk factors for sebaceous gland diseases and their relationship to gastrointestinal dysfunction in Han adolescents. J Dermatol. 2008;35:555-561.
9. Attaluri A, Jackson M, Valestin J, et al. Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS [published online ahead of print December 1, 2009]. Am J Gastroenterol. 2010;105:1407-1411.
10. Khalif IL, Quigley EM, Konovitch EA, et al. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation [published online ahead of print October 5, 2005]. Dig Liver Dis. 2005;37:838-849.
11. Wang SX, Wu WC. Effects of psychological stress on small intestinal motility and bacteria and mucosa in mice. World J Gastroenterol. 2005;11:2016-2021.
12. Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication [published online ahead of print May 5, 2008]. Clin Gastroenterol Hepatol. 2008;6:759-764.
13. Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part II-contemporary contextual research. Gut Pathog. 2013;5:3.
14. Moschen AR, Wieser V, Tilg H. Dietary factors: major regulators of the gut's microbiota [published online ahead of print August 7, 2012]. Gut Liver. 2012;6:411-416.
15. Kim J, Ko Y, Park YK, et al. Dietary effect of lactoferrin-enriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris. Nutrition. 2010;26:902-909.
16. Fitz-Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne [published online ahead of print January 21, 2013]. J Invest Dermatol. doi:10.1038/jid.2013.21.